Results 91 to 100 of about 424,058 (165)

Effectiveness and evolution of anti-SARS-CoV-2 spike protein titers after three doses of COVID-19 vaccination in people with HIV

Journal of Microbiology, Immunology and Infection
Background: Real-world vaccine effectiveness following the third dose of vaccination against SARS-CoV-2 remains less investigated among people with HIV (PWH).
Wang-Da Liu, Meng-Shuan Lin, Hsin-Yun Sun, Ming-Chieh Shih, Yu-Chung Chuang, Yu-Shan Huang, Kuan-Yin Lin, Guei-Chi Li, Pei-Ying Wu, Ling-Ya Chen, Wen-Chun Liu, Yi-Ching Su, Pu-Chi He, Yi-Ting Chen, Chia-Yi Lin, Yu-Chen Cheng, Yi Yao, Yi-Chen Yeh, Chia-Chi Liu, Mei-Yan Pan, Yu-Zhen Luo, Hsi-Yen Chang, Jann-Tay Wang, Wang-Huei Sheng, Szu-Min Hsieh, Sui-Yuan Chang, Chien-Ching Hung   +26 more
doaj   +1 more source

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

, 2020
BACKGROUND: Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle-encapsulated mRNA-based vaccine that encodes the prefusion ...
Mascola, John, Baden, Lindsey R, Follmann, Dean, Miller, Jacqueline, Bennett, Hamilton, Rouphael, Nadine, Kotloff, Karen, Segall, Nathan, Knightly, Conor, Novak, Rick, Polakowski, Laura, Graham, Barney S, Fierro, Carlos, Schwartz, Howard, Diemert, David, Han, Shu, Gilbert, Peter, Frey, Sharon, Essink, Brandon, Creech, C Buddy, Marovich, Mary, El Sahly, Hana M, Corey, Larry, Brosz, Adam, Zaks, Tal, Khetan, Shishir, Ledgerwood, Julie, Deng, Weiping, McGettigan, John, Leav, Brett, Zhou, Honghong, Kehtan, Shishir, Neuzil, Kathleen, Janes, Holly, Spector, Stephen A, Pajon, Rolando, Solis, Joel, Ivarsson, Melanie, COVE Study Group   +38 more
core   +1 more source

Adverse events reported after administration of BNT162b2 and mRNA-1273 COVID-19 vaccines among hospital workers: a cross-sectional survey-based study in a Spanish hospital

, 2021
Background: The World Health Organization declared COVID-19 a pandemic in March 2020. The first vaccine became available in December, with practically no post-marketing data.
Valera-Rubio, Marta, Castillejo García, Raquel, Cordero-Ramos, Jaime, López Márquez, María Reyes, Calleja-Hernández, Miguel Ángel, Cruz-Salgado, Óscar, Sierra-Torres, María Isabel   +6 more
core   +1 more source

Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system [PDF]

, 2015
This work was supported by Medical Research Scotland (FRG353 to VAS), the FP7- Directorate-General for Research and Innovation of the European Commission (EU HEALTHF4-2012-305033 to Coordinating Action Systems Medicine to DJH); the Chief Scientist Office
Smith, V. Anne, Um, In Hwa, Harrison, David J, Langdon, Simon, Smith, V Anne, Koussounadis, Antonis, Harrison, David James, Langdon, Simon P.   +7 more
core   +1 more source

Immunoglobulin M and immunoglobulin G repertoire sequencing data of two donors first infected with SARS-CoV-2 then vaccinated with mRNA-1273

, 2023
Immunoglobulin M (IgM) and immunoglobulin G (IgG) repertoire sequencing libraries from two donors who were first infected by index SARS-CoV-2, then vaccinated by the mRNA-1273 vaccine.
Gunilla B. Karlsson Hedestam (14075894), Aron Stålmarck (14075824), Ben Murrell (14075906), Mark Chernyshev (14047377), C. Garrett Rappazzo (14075822), Ruth I. Connor (14075815), Mrunal Sakharkar (14075813), Haley L. Dugan (14075818), Laura M. Walker (14075828), Martin Corcoran (14075896), Mattias M.N. Forsell (14075826), Daniel J. Sheward (14075821), Peter F. Wright (14075827)   +12 more
core   +1 more source

Anti-SARS-CoV-2 antibody dynamics after primary vaccination with two-dose inactivated whole-virus vaccine, heterologous mRNA-1273 vaccine booster, and Omicron breakthrough infection in Indonesian health care workers

BMC Infectious Diseases
Background Data on the dynamics and persistence of humoral immunity against SARS-CoV-2 after primary vaccination with two-dose inactivated vaccine (CoronaVac) are limited.
Suwarti Suwarti, Gilbert Lazarus, Sabighoh Zanjabila, Robert Sinto, Fransiska Fransiska, Theresia Deborah, Dwi Oktavia, Junaidah Junaidah, Santayana Santayana, Henry Surendra, Jeng Yuliana, Herlina Pardosi, Nunung Nuraeni, Saraswati Soebianto, Novi Dwi Susilowati, Decy Subekti, Ariel Pradipta, J. Kevin Baird, Le Van Tan, Susanna Dunachie, Anuraj H. Shankar, Erni J. Nelwan, Raph L. Hamers, SEACOVARIANTS Consortium   +23 more
doaj   +1 more source

mRNA-vacciner mot SARS-CoV-2 (Pfizer BionTech BNT162b och mRNA-1273 Moderna) -analys av säkerhet och effektivitet

, 2022
Introduction: The coronavirus is an RNA virus with a lipid envelope. The initially known coronaviruses are (MERS-CoV and SARS-CoV) which caused fatal endemics in 2002 and 2012.
Mohamedhusein, Doaa Rashad
core   +1 more source

mrna-1273/tozinameran [PDF]

Reactions Weekly, 2021
  +9 more sources

Moderna (mRNA Vaccine) for COVID-19: A Leap in Vaccine World

Pharmaceutical and Biomedical Research, 2022
In December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) appeared and spread worldwide, triggering a pandemic of respiratory illness. So, there was an urgent need for vaccines worldwide.
Anita Rani Bhatia, Arpita Saxena, Nitin Tyagi, Peyir Bagra, Paarth Bhatia   +4 more
doaj  

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source